文献
J-GLOBAL ID:202002227898610199
整理番号:20A0966563
HLA-B*51:01とCYP2C9*3は日本人集団におけるフェニトイン誘発性発疹に対する危険因子である:Biobank日本プロジェクトからのデータの分析【JST・京大機械翻訳】
HLA-B*51:01 and CYP2C9*3 Are Risk Factors for Phenytoin-Induced Eruption in the Japanese Population: Analysis of Data From the Biobank Japan Project
著者 (16件):
Hikino Keiko
(Laboratory for Pharmacogenomics, RIKEN Center for Integrative Medical Sciences, Yokohama City, Kanagawa, Japan)
,
Ozeki Takeshi
(Laboratory for Pharmacogenomics, RIKEN Center for Integrative Medical Sciences, Yokohama City, Kanagawa, Japan)
,
Koido Masaru
(Laboratory for Statistical and Translational Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama City, Kanagawa, Japan)
,
Terao Chikashi
(Laboratory for Statistical and Translational Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama City, Kanagawa, Japan)
,
Kamatani Yoichiro
(Laboratory for Statistical and Translational Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama City, Kanagawa, Japan)
,
Kamatani Yoichiro
(Laboratory of Complex Trait Genomics, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan)
,
Mizukawa Yoshiko
(Department of Dermatology, Kyorin University School of Medicine, Tokyo, Japan)
,
Shiohara Tetsuo
(Department of Dermatology, Kyorin University School of Medicine, Tokyo, Japan)
,
Tohyama Mikiko
(Department of Dermatology, Ehime University Graduate School of Medicine, Ehime, Japan)
,
Azukizawa Hiroaki
(Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan)
,
Aihara Michiko
(Department of Environmental Immuno-Dermatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan)
,
Nihara Hiroyuki
(Department of Dermatology, Faculty of Medicine, Shimane University, Shimane, Japan)
,
Morita Eishin
(Department of Dermatology, Faculty of Medicine, Shimane University, Shimane, Japan)
,
Murakami Yoshinori
(Division of Molecular Pathology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan)
,
Kubo Michiaki
(RIKEN Center for Integrative Medical Sciences, Yokohama City, Kanagawa, Japan)
,
Mushiroda Taisei
(Laboratory for Pharmacogenomics, RIKEN Center for Integrative Medical Sciences, Yokohama City, Kanagawa, Japan)
資料名:
Clinical Pharmacology & Therapeutics
(Clinical Pharmacology & Therapeutics)
巻:
107
号:
5
ページ:
1170-1178
発行年:
2020年
JST資料番号:
A0721B
ISSN:
0009-9236
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)